PharMerica to Present at the Credit Suisse 2012 Healthcare Conference

Business Wirevia The Motley Fool
Updated

PharMerica to Present at the Credit Suisse 2012 Healthcare Conference

LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYS: PMC) , a national provider of institutional pharmacy and hospital pharmacy management services, today announced that Michael J. Culotta, Executive Vice President and Chief Financial Officer, will make a presentation regarding the Company at the Credit Suisse 2012 Healthcare Conference in Phoenix, Arizona, on Wednesday, November 14, 2012, at 3:30 p.m. Mountain Standard Time.


The Company also announced that a live broadcast of its conference presentation, as well as any written materials accompanying the presentation, will be available on the "For Investors" tab of the Company's website, www.pharmerica.com, under "Webcasts and Presentations." In addition, the webcast, transcript and written materials will be archived on the Company's website following the event.

About PharMerica

PharMerica Corporation is a leading institutional pharmacy services company servicing healthcare facilities in the United States. PharMerica operates institutional pharmacies in 44 states. PharMerica's customers are institutional healthcare providers, such as nursing centers, assisted living facilities, hospitals and other long-term care providers. The Company also provides pharmacy management services to long-term care hospitals.



PharMerica Corporation
Michael J. Culotta, 502-627-7475
Executive Vice President and Chief Financial Officer

KEYWORDS: United States North America Kentucky

INDUSTRY KEYWORDS:

The article PharMerica to Present at the Credit Suisse 2012 Healthcare Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement